HIV/AIDS Therapy

Indian firm withdraws its HIV drugs from World Health Organization list

Published in AIDS Weekly, November 29th, 2004

India's Ranbaxy Laboratories is withdrawing all of its generic versions of antiretroviral drugs from the World Health Organization (WHO)'s list of approved HIV medicines, saying it is uncertain they are biologically the same as the patented drugs.

Ranbaxy found "discrepancies in the documentation," which meant that it was unable to prove in studies that its generic HIV treatments are equivalent to the original medicines, the U.N. health agency said in a statement.

In India, a Ranbaxy spokesman said he had no immediate comment.

The company has already proposed dates to submit reports on new studies of the drugs, WHO said. The first...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2004-11-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry